Subfield atrophy pattern in temporal lobe epilepsy with and without mesial sclerosis detected by high‐resolution MRI at 4 Tesla: Preliminary results
Susanne G. Mueller(University of California, San Francisco), Michael W. Weiner(University of California, San Francisco), Kenneth D. Laxer(California Pacific Medical Center), Jerome Barakos(Sutter Health), Ian Cheong(Western University), Paul A. Garcia(University of California, San Francisco)
Cited by 93
Related Papers
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
|Neurology|2009|741
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
|The Lancet Neurology|2010|696
Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiome
|Alzheimer s & Dementia|2018|690